The purpose of this work was to optimize and evaluate different parameters of the CEST acquisition protocol at 7 Tesla to be able to detect the glycoCEST signal in the human liver. The so far optimized parameters were determined as 65 frequency offsets, 60 saturation pulses of 25 ms duration and an effective B1 of 1.5uT. As conclusion, we have demonstrated that in-vivo liver glycoCEST can be detected in the human liver by using a CEST acquisition at 7T. The parameters can be further optimized to obtain a stronger glycoCEST effect.
This abstract and the presentation materials are available to members only; a login is required.